CT-P39 (omalizumab biosimilar) for previously treated chronic spontaneous urticaria TS ID 11832Status:Topic selectionProgramme:Technology appraisal guidanceExpected publication date: TBC
Budesonide oral suspension for maintaining remission of eosinophilic oesophagitis in people 2 years and over TS ID 12082Status:Topic selectionProgramme:Technology appraisal guidanceExpected publication date: TBC